業績

研究紹介

研究紹介はこちら

具体的な発表論文の紹介

英文業績 2012年～
＊当科医局員がthird authorまで、last author, corresponding authorのどれかである論文のみ

2023年

1.Orihashi R, Imamura Y, Yamada S, Monji A, Mizoguchi Y.
Psychiatry and Clinical Neurosciences Reports. 2023 2:e97.

2.Ohishi-Fukuchi J, Imamura Y, Orihashi R, Kunitake H, Kunitake Y, Tateishi H, Yamada S, Monji A, Mizoguchi Y.
Psychogeriatrics. 2023 Jul;23(4):675-681.

3.Matsuoka A, Sogawa R, Murakawa-Hirachi T, Mizoguchi Y, Monji A, Shimanoe C, Shinada K, Koami H, Sakamoto Y.
Gen Hosp Psychiatry. 2023 Jul-Aug;83:123-129.

4.Tateishi H, Matsushima J, Kunitake H, Imamura Y, Kunitake Y, Murakawa T, Mawatari S, Kojima R, Fujii Y, Kikuchi J, Fukuchi J, Sakemura Y, Shiraishi T, Nagahama C, Maekawa T, Asami T, Mizoguchi Y, Monji A.
Neuropsychopharmacol Rep.2023 Jun;43(2):222-227.

5.Kunitake Y, Mizoguchi Y, Imamura Y, Kunitake H, Orihashi R, Matsushima J, Tateishi H, Murakawa-Hirachi T, Yamada S, Monji A.
Compr Psychoneuroendocrinol. 2022 Dec 28;13:100166.

6.Sogawa R, Matsuoka A, Murakawa-Hirachi T, Kikkawa N, Kamo M, Tobita S, Shinada K, Mizoguchi Y, Monji A, Sakamoto Y, Shimanoe C.
Gen Hosp Psychiatry. 2023 Jan-Feb;80:43-47.

2022年

1.Shiba S, Fukuchi J, Hirachi-Murakawa T, Tateishi H, Kunitake Y, Mizoguchi Y, Monji A.
Prim Care Companion CNS Disord. 2022 Oct 13;24(5):21cr03207.

2.Orihashi R, Imamura Y, Yamada S, Monji A, Mizoguchi Y.
BMC Geriatr. 2022 Sep 21;22(1):765.

3.Tateishi H, Setoyama D, Kato TA, Kang D, Matsushima J, Nogami K, Mawatari S, Kojima R, Fujii Y, Sakemura Y, Shiraishi T, Imamura Y, Maekawa T, Asami T, Mizoguchi Y, Monji A.
Psychiatry Res. 2022 Jul;313:114636.

4.Tateishi H, Mizoguchi Y, Monji A.
Front Psychiatry. 2022 Feb 24;13:834425.

2021年

1.Orihashi R, Mizoguchi Y, Imamura Y, Yamada S, Monji A.
Front Aging Neurosci. 2021 Apr 26;13:665612.

2.Ohto A, Mizoguchi Y, Imamura Y, Kojima N, Yamada S, Monji A.
Psychogeriatrics. 2021 Apr 20. doi: 10.1111/psyg.12695.

3.Tateishi H, Setoyama D, Kang D, Matsushima J, Kojima R, Fujii Y, Mawatari S, Kikuchi J, Sakemura Y, Fukuchi J, Shiraishi T, Maekawa T, Kato TA, Asami T, Mizoguchi Y, Monji A.
J Psychiatr Res. 2021 Apr 9;138:194-199. doi: 10.1016/j.jpsychires.2021.04.009.

4.Monji A, Tateishi H, Murakawa T, Matsushima J, Kunitake Y, Shiraishi T, Kojima R, Inaba T, Kato T, Mizoguchi Y.
Case Rep Psychiatry. 2021 Mar 2;2021:6663824. doi: 10.1155/2021/6663824.

5.Mizoguchi Y, Ohgidani M, Haraguchi Y, Murakawa-Hirachi T, Kato TA, Monji A.
Glia. 2021 Jul;69(7):1694-1708. doi: 10.1002/glia.23996. Epub 2021 Mar 19

6.Murakawa-Hirachi T, Mizoguchi Y, Ohgidani M, Haraguchi Y, Monji A.
Sci Rep. 2021 Mar 17;11(1):6151. doi: 10.1038/s41598-021-85625-4.

7.Akira Monji.
Clin & Exp Neuroimmunol. 11 February 2021

8.Iwanaga H, Ueno T, Oribe N, Hashimoto M, Nishimura J, Nakayama N, Haraguchi N, Tateishi H, Kunitake Y, Mizoguchi Y, Monji A.
J Pers Med. 2021 Dec 6;11(12):1315.

9.Monji A, Mizoguchi Y.
Neuropsychobiology. 2022;81(2):98-103.

10.Sogawa R, Tobita S, Monji A, Murakawa-Hirachi T, Mizoguchi Y, Sakamoto Y, Irie H, Shimanoe C.
Case Rep Psychiatry. 2021 Jun 22;2021:9934037.


2020年

Mizoguchi Y, Yao H, Imamura Y, Hashimoto M, Monji A.
Lower brain-derived neurotrophic factor levels are associated with age-related memory impairment in community-dwelling older adults: the Sefuri study.
Sci Rep.2020 Oct 5;10(1):16442. PMID: 33020545

Orihashi R, Mizoguchi Y, Imamura Y, Yamada S, Ueno T, Monji A.
Oxytocin and elderly MRI-based hippocampus and amygdala volume: a 7-year follow-up study.
Brain Commun. 2020 Jun 11;2(2):fcaa081. PMID: 32954331

Tobita S, Sogawa R, Murakawa T, Kimura S, Tasaki M, Sakamoto Y, Monji A, Irie H.
The importance of monitoring renal function and concomitant medication to avoid toxicity in patients taking lithium.
Int Clin Psychopharmacol. 2020 Jun 11. doi: 10.1097/YIC.0000000000000320. Online ahead of print.PMID: 32541381

Tateishi H, Mizoguchi Y, Kawaguchi A, Imamura Y, Matsushima J, Kunitake H, Murakawa T, Haraguchi Y, Kunitake Y, Maekawa T, Kato TA, Asami T, Monji A.
Changes in interleukin-1　beta　induced　by　TMS　are　significantly　correlated　with　partial　improvement　of　cognitive dysfunction in treatment-resistant depression: a pilot study
Psychiatry Res. 2020 Apr 16　(in press)

Kunitake Y,Imamura Y,Mizoguchi Y,Matsushima J,Tateishi H,Murakawa-Hirachi T,Nabeta H,Kawashima T,Kojima N,Yamada S,Monji A.
Serum Oxytocin Levels and Logical Memory in Older People in Rural Japan.
J Geriatr Psychiatry Neurol.2020 Apr 1

2019年

Mizoguchi Y , Oyama JI , Imamura Y , Node K , Monji A
The effect of continuous positive airway pressure (CPAP) treatment on serum levels of proBDNF and mature BDNF in patients with obstructive sleep apnea.
Sleep Breath. 2019 Sep;23(3):889-892

Tateishi H , Nishihara M , Kawaguchi A , Matsushima J , Murakawa T , Haraguchi Y , Kunitake Y , Maekawa T , Kato TA , Asami T , Mizoguchi Y , Monji A
Improvement Of Frontal Lobe Dysfunction And White Matter Integrity By rTMS In Treatment-Resistant Depression.
Neuropsychiatric Disease and Treatment. 2019 Nov 6;15:3079-3087

Aita C, Mizoguchi Y, Yamamoto M, SeguchI Y, Yatsuga C, Nishimura T, Sugimoto Y, Takahashi D, Nishihara R, Ueno T, Nakayama M, Kuroki T, Nabeta H, Imamura Y, Monji A.
Oxytocin levels and sex differences in autism spectrum disorder with severe intellectual disabilities.
Psychiatry Res. 2019 Mar;273:67-74.

Yao H, Mizoguchi Y, Monji A, Yakushiji Y, Takashima Y, Uchino A, Yuzuriha T, Hashimoto M.
Low-Grade Inflammation Is Associated with Apathy Indirectly via Deep White Matter Lesions in Community-Dwelling Older Adults: The Sefuri Study.
Int J Mol Sci. 2019 Apr 17;20(8)

2018年

Fujii Y, Mizoguchi Y, Masuoka J, Matsuda Y, Abe T, Anzai K, Kunitake Y, Tateishi H, Inaba T, Murakawa T, Kato TA, Monji A.
Cushing’s Syndrome and Psychosis: A Case Report and Literature Review.
Prim Care Companion CNS Disord. 2018 Sep 13;20(5)

Inaba T, Sogawa R, Mizoguchi Y, Tateishi H, Kunitake Y, Kato TA, Monji A.
Lamotrigine Rechallenge in Treatment-Resistant Bipolar Disorder.
Prim Care Companion CNS Disord. 2018 Mar 29;20(2).

Fujita T, Mizoguchi Y, Kunitake Y, Tateishi H, Inaba T, Kato TA, Monji A.
Second-Generation Antipsychotic-Induced Hypoglycemia.
Prim Care Companion CNS Disord. 2018 Jan 25;20(1).

2017年

Kunitake Y, Mizoguchi Y, Sogawa R, Matsushima J, Kato TA, Kawashima T, Monji A.
Effect of Excessive Coffee Consumption on the Clinical Course of a Patient With Bipolar Disorder: A Case Report and Literature Review.
Clin Neuropharmacol. 2017 Jul-Aug;40(4):160-162. doi: 10.1097/WNF.0000000000000222

Mizoguchi Y, Monji A.
TRPC Channels and Brain Inflammation.
Adv Exp Med Biol. 2017;976:111-121.doi: 10.1007/978-94-024-1088-4_10.

Mizoguchi Y, Monji A.
Microglial Intracellular Ca(2+) Signaling in Synaptic Development and its Alterations in Neurodevelopmental Disorders.
Front Cell Neurosci. 2017 Mar 17;11:69. doi: 10.3389/fncel.2017.00069.eCollection 2017. Review.

Imamura Y, Mizoguchi Y, Nabeta H, Haraguchi Y, Matsushima J, Kojima N, Kawashima T, Yamada S, Monji A.
An association between belief in life after death and serum oxytocin in older people in rural Japan.
Int J Geriatr Psychiatry. 2017 Jan;32(1) :102-109. doi: 10.1002/gps.4453. Epub 2016 Feb 21.

Ohgidani M, Kato TA, Haraguchi Y, Matsushima T, Mizoguchi Y, Murakawa-Hirachi T, Sagata N, Monji A, Kanba S.
Microglial CD206 Gene Has Potential as a State Marker of Bipolar Disorder.
Front Immunol. 2017 Jan 9;7:676. doi: 10.3389/fimmu.2016.00676.e\collection 2016.

Haraguchi Y*, Mizoguchi Y*, Ohgidani M, Imamura Y, Murakawa-Hirachi T, Nabeta H, Tateishi H, Kato TA, Monji A. （2017）(*Equal author contribution)
Donepezil suppresses intracellular Ca2+ mobilization through the PI3K pathway in rodent microglia.
Journal of Neuroinflammation. 2017 Dec 22;14(1):258.

2016年

Tateishi H, Hirachi T, Maruo J, Haraguchi Y, Noguchi T, Mizoguchi Y, Kato TA, Kawashima T, Monji A.
Neurocognitive Disorders in Chronic Kidney Disease: A Case Report and Literature Review.
Psychosomatics. 2016 Jan-Feb;57(1):107-12.

Haraguchi Y, Mizoguchi Y, Noguchi T, Arai T, Fukuyama J, Kato TA,Kawashima T, Monji A.
A patient with Alzheimer’s disease complicated by elderly-onset Cushing’s syndrome who had undergone surgical treatment for adrenocorticotropic hormone-independent macronodular adrenal hyperplasia.
Psychogeriatrics. 2016;16(4):274–6.

Maruo J, Haraguchi Y, Tateishi H, Noguchi T, Mizoguchi Y, Kato TA, Kawashima T, Monji A.
Abnormal behaviours during pramipexole treatment for Cotard’s syndrome: a case report.
Psychogeriatrics. 2016;16(4):283–6.

Imamura Y, Mizoguchi Y, Nabeta H, Haraguchi Y, Matsushima J, Kojima N, Kawashima T, Yamada S, Monji A.
An association between belief in life after death and serum oxytocin in older people in rural Japan.
.Int J Geriatr Psychiatry. 2016 Feb 21. doi: 10.1002/gps.4453. [Epub ahead of print]

Sogawa R, Mochinaga S, Inaba T, Matsushima J, Mizoguchi Y, Kawashima T, Fujito H, Monji A.
Safety of Long-term Use of Lamotrigine for the Treatment of Psychiatric Disorders.
Clin Neuropharmacol. 2016 Jul 19. [Epub ahead of print]

Sogawa R , Shimomura Y , Minami C , Maruo J , Kunitake Y , Mizoguchi Y , Kawashima T , Monji A , Hara H.
Aripiprazole-Associated Hypoprolactinemia in the Clinical Setting.
J Clin Psychopharmacol. 2016 Jun 8 ; ():.

2015年

Hirachi T, Ishii H, Tada Y, Noguchi T, Haraguchi Y, Tateishi H, Mizoguchi Y, Kato TA, Kawashima T, Monji A.　
Mania occurring during systemic lupus erythematosus relapse and its amelioration on clinical and neuroimaging follow-up.
Lupus. 2015;24(9):990-993

Matsushima J, Kawashima T, Nabeta H, Imamura Y, Watanabe I, Mizoguchi Y,Kojima N, Yamada S, Monji A.
Association of inflammatory biomarkers with depressive symptoms and cognitive decline in a community-dwelling healthy older sample: a 3-year follow-up study.
J Affect Disord. 2015;173:9-14

Imamura Y, Mizoguchi Y, Nabeta H, Matsushima J, Watanabe I, Kojima N,Kawashima T, Yamada S, Monji A.
Belief in life after death, salivary 3-methoxy-4-hydroxyphenylglycol, and well-being among older people without cognitive impairment dwelling in rural Japan.
Int J Geriatr Psychiatry. 2015 ;30(3):256-64.

2014年

Mizoguchi Y, Kato TA, Horikawa H, Monji A.
Microglial intracellular Ca(2+) signaling as a target of antipsychotic actions for the treatment of schizophrenia.
Front Cell Neurosci. 2014 ;8:370.

Mizoguchi Y, Kato TA, Seki Y, Ohgidani M, Sagata N, Horikawa H, Yamauchi Y, Sato-Kasai M, Hayakawa K, Inoue R, Kanba S, Monji A.
Brain-derived neurotrophic factor (BDNF) induces sustained intracellular Ca2+ elevation through the up-regulation of surface transient receptor potential 3 (TRPC3) channels in rodent microglia.
J Biol Chem. 2014;289(26):18549-55.

Nabeta H, Mizoguchi Y, Matsushima J, Imamura Y, Watanabe I, Tateishi T, Kojima N, Kawashima T, Yamada S, Monji A.
Association of salivary cortisol levels and later depressive state in elderly people living in a rural community: a 3-year follow-up study.
J Affect Disord. 2014 ;158:85-9

Monji A, Motomura K, Mizoguchi Y, Ohara T, Baba S, Yoshiura T, Kanba S.
A case of late-onset bipolar disorder with severely abnormal behavior and neuroimaging observations very similar to those of frontotemporal dementia.
J Neuropsychiatry Clin Neurosci. 2014;26(1):E35

Mizoguchi Y, Monji A.
A case of psychotic depression successfully treated with sertraline as monotherapy.
J Neuropsychiatry Clin Neurosci. 2014;26(1):E12.

2013年

Seki Y, Kato TA, Monji A, Mizoguchi Y, Horikawa H, Sato-Kasai M, Yoshiga D,Kanba S.　
Pretreatment of aripiprazole and minocycline, but not haloperidol, suppresses oligodendrocyte damage from interferon-γ-stimulated microglia in co-culture model.
Schizophr Res. 2013;151(1-3):20-8.

Monji A, Kato TA, Mizoguchi Y, Horikawa H, Seki Y, Kasai M, Yamauchi Y, Yamada S, Kanba S.
Neuroinflammation in schizophrenia especially focused on the role of microglia.
Prog Neuropsychopharmacol Biol Psychiatry. 2013 ;42:115-21.

Egami M, Imamura Y, Nabeta H, Mizoguchi Y, Yamada S.
Saliva levels of 3-methoxy-4-hydroxyphenylglycol and clinical efficacy of mirtazapine or selective serotonin reuptake inhibitors in patients with major depression.
Hum Psychopharmacol. 2013;28(1):7-14.

2012年

Mizoguchi Y
Levomepromazine-Induced Retrograde Ejaculation.
J Neuropsychiatry Clin Neurosci. 2012;.24(1): E32

Mizoguchi Y, Sakami A, Imamura Y, Tsuruta T, Egami M, Yamada S.
The effect of oral presentation on salivary 3-methoxy-4-hydroxy-phenylglycol (MHPG) and cortisol concentrations in training doctors: a preliminary study.
Endocrine. 2012;42(3):752-3.

Watanabe I, Li GY, Imamura Y, Nabeta H, Kunitake Y, Ishii H, Haraguchi M, Furukawa Y, Tateishi H, Kojima N, Mizoguchi Y, Yamada S.
Baseline saliva level of 3-methoxy-4-hydroxyphenylglycole (MHPG) associates with a consequent cognitive decline in non-demented elderly subjects: three-years follow-up study.
Psychiatry Res. 2012;195(3):125-8

Itaru Watanabe 1, Guang-Ying Li, Yoshiomi Imamura, Hiromi Nabeta, Yutaka Kunitake, Hironobu Ishii, Masanori Haraguchi, Naoki Kojima, Shigeto Yamada
Association of Saliva 3-methoxy-4-hydroxyphenylglycol Levels and a Later Depressive State in Older Subjects Living in a Rural Community: 3-year Follow-Up Study
Int J Geriatr Psychiatry. 2012 Mar;27(3):321-6. doi: 10.1002/gps.2729. Epub 2011 Apr 27.

Mizoguchi Y, Monji A, Yamada S.
Dysgeusia successfully treated with sertraline.
J Neuropsychiatry Clin Neurosci. 2012;24(2):E42

このページの先頭に戻る